Aligos Therapeutics, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2025-02-28: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2025-02-11; Total offering amount $105,003,206.
- 2023-11-07: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2023-10-25; Total offering amount $92,150,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|
| 2025-02-28 | Rule 506(b) | Equity; OptionToAcquire; SecurityToBeAcquired | 2025-02-11 | $105,003,206 | $105,003,206 | $0 | 12 |
|---|
| 2023-11-07 | Rule 506(b) | Equity; OptionToAcquire; SecurityToBeAcquired | 2023-10-25 | $92,150,000 | $92,150,000 | $0 | 11 |
|---|